메뉴 건너뛰기




Volumn 17, Issue 7, 2010, Pages 1740-1746

Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: The French experience

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARMUSTINE; CORTICOSTEROID; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; BIOMATERIAL; DACARBAZINE; DECANEDIOIC ACID-4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(BENZOIC ACID) COPOLYMER; DECANOIC ACID DERIVATIVE; DRUG CARRIER; POLYESTER;

EID: 77955706783     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1081-5     Document Type: Article
Times cited : (64)

References (28)
  • 1
    • 0032601052 scopus 로고    scopus 로고
    • Descriptive epidemiology of primary brain and CNS tumors: Results from the central brain tumor registry of the United States, 1990-1994
    • Surawicz TS, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999;1(1):14-25.
    • (1999) Neuro. Oncol. , vol.1 , Issue.1 , pp. 14-25
    • Surawicz, T.S.1
  • 2
    • 0019142613 scopus 로고
    • Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
    • Walker MD, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980;303(23):1323-9.
    • (1980) N. Engl. J. Med. , vol.303 , Issue.23 , pp. 1323-1329
    • Walker, M.D.1
  • 3
    • 0027516695 scopus 로고
    • Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
    • Fine HA, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71(8):2585-97.
    • (1993) Cancer , vol.71 , Issue.8 , pp. 2585-2597
    • Fine, H.A.1
  • 4
    • 0028917333 scopus 로고
    • Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas the polymer-brain tumor treatment group
    • Brem H, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas The Polymer-brain Tumor Treatment Group. Lancet. 1995;345(8956):1008-12.
    • (1995) Lancet , vol.345 , Issue.8956 , pp. 1008-1012
    • Brem, H.1
  • 5
    • 0037384037 scopus 로고    scopus 로고
    • A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
    • Westphal M, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003;5(2):79-88.
    • (2003) Neuro. Oncol. , vol.5 , Issue.2 , pp. 79-88
    • Westphal, M.1
  • 6
    • 33644787355 scopus 로고    scopus 로고
    • Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial
    • Westphal M, et al. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006;148(3):269-75.
    • (2006) Acta Neurochir (Wien) , vol.148 , Issue.3 , pp. 269-275
    • Westphal, M.1
  • 7
    • 20044366163 scopus 로고    scopus 로고
    • Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    • Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-96.
    • (2005) N. Engl. J. Med. , vol.352 , Issue.10 , pp. 987-996
    • Stupp, R.1
  • 8
    • 36448938519 scopus 로고    scopus 로고
    • A phase 2 study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion [abstract]
    • LaRocca RV, et al. A phase 2 study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion [abstract]. Neuro Oncol. 2006;8(4):445.
    • (2006) Neuro. Oncol. , vol.8 , Issue.4 , pp. 445
    • LaRocca, R.V.1
  • 9
    • 49649104978 scopus 로고    scopus 로고
    • Mechanisms of chemoresistance to alkylating agents in malignant glioma
    • Sarkaria JN, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res. 2008;14(10):2900-8.
    • (2008) Clin. Cancer Res. , vol.14 , Issue.10 , pp. 2900-2908
    • Sarkaria, J.N.1
  • 10
    • 0033739125 scopus 로고    scopus 로고
    • Gliomas: WHO and sainte-anne hospital classifications
    • Daumas-Duport C, et al. [Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol. 2000;20(5):413-28.
    • (2000) Ann. Pathol. , vol.20 , Issue.5 , pp. 413-428
    • Daumas-Duport, C.1
  • 11
    • 67649372741 scopus 로고    scopus 로고
    • Overall survival of primary glioblastoma (GBM) patients receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy [abstract]
    • Rich JN, et al. Overall survival of primary glioblastoma (GBM) patients receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy [abstract]. J Clin Oncol. 2007;25:2070.
    • (2007) J. Clin. Oncol. , vol.25 , pp. 2070
    • Rich, J.N.1
  • 12
    • 34247540921 scopus 로고    scopus 로고
    • Interstitial chemotherapy for malignant gliomas: The johns hopkins experience
    • Lawson HC, et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol. 2007;83(1):61-70.
    • (2007) J. Neurooncol , vol.83 , Issue.1 , pp. 61-70
    • Lawson, H.C.1
  • 13
    • 0037443855 scopus 로고    scopus 로고
    • Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement
    • McGovern PC, et al. Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. Clin Infect Dis. 2003;36(6):759-65.
    • (2003) Clin. Infect. Dis. , vol.36 , Issue.6 , pp. 759-765
    • McGovern, P.C.1
  • 14
    • 51649126636 scopus 로고    scopus 로고
    • Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience
    • Attenello FJ, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15(10):2887-93.
    • (2008) Ann. Surg. Oncol. , vol.15 , Issue.10 , pp. 2887-2893
    • Attenello, F.J.1
  • 15
    • 0034032696 scopus 로고    scopus 로고
    • Tumor bed cyst formation after BCNU wafer implantation: Report of two cases
    • Engelhard HH, Tumor bed cyst formation after BCNU wafer implantation: report of two cases. Surg Neurol. 2000;53(3):220-4.
    • (2000) Surg. Neurol. , vol.53 , Issue.3 , pp. 220-224
    • Engelhard, H.H.1
  • 16
    • 1942473722 scopus 로고    scopus 로고
    • Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: Implications for patient management
    • Kleinberg LR, et al. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest. 2004;22(1):1-9.
    • (2004) Cancer Invest. , vol.22 , Issue.1 , pp. 1-9
    • Kleinberg, L.R.1
  • 17
    • 0036241641 scopus 로고    scopus 로고
    • Management of tumor bed cysts after chemo-therapeutic wafer implantation Report of four cases
    • McGirt MJ, et al. Management of tumor bed cysts after chemo-therapeutic wafer implantation Report of four cases. J Neurosurg. 2002;96(5):941-5.
    • (2002) J. Neurosurg. , vol.96 , Issue.5 , pp. 941-945
    • McGirt, M.J.1
  • 18
    • 57049163197 scopus 로고    scopus 로고
    • The role of proton magnetic resonance spectroscopy in the diagnosis and categorization of cerebral abscesses
    • Kapsalaki EZ, Gotsis ED, Fountas KN. The role of proton magnetic resonance spectroscopy in the diagnosis and categorization of cerebral abscesses. Neurosurg Focus. 2008;24(6):E7.
    • (2008) Neurosurg. Focus , vol.24 , Issue.6
    • Kapsalaki, E.Z.1    Gotsis, E.D.2    Fountas, K.N.3
  • 19
    • 0036732590 scopus 로고    scopus 로고
    • Brain abscess and necrotic brain tumor: Discrimination with proton MR spectroscopy and diffusion-weighted imaging
    • Lai PH, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol. 2002;23(8):1369-77.
    • (2002) AJNR Am. J. Neuroradiol , vol.23 , Issue.8 , pp. 1369-1377
    • Lai, P.H.1
  • 20
    • 18044402671 scopus 로고    scopus 로고
    • Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
    • Gururangan S, et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol. 2001;3(4):246-50.
    • (2001) Neuro. Oncol. , vol.3 , Issue.4 , pp. 246-250
    • Gururangan, S.1
  • 21
    • 0032984584 scopus 로고    scopus 로고
    • Morbidity and survival after 1, 3-bis (2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: A retrospective case-matched cohort series
    • Subach BR, et al. Morbidity and survival after 1, 3-bis (2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery. 1999;45(1):17-22.
    • (1999) Neurosurgery , vol.45 , Issue.1 , pp. 17-22
    • Subach, B.R.1
  • 22
    • 14644431736 scopus 로고    scopus 로고
    • Cerebral edema associated with Gliadel wafers: Two case studies
    • Weber EL, Goebel EA. Cerebral edema associated with Gliadel wafers: two case studies. Neuro Oncol. 2005;7(1):84-9.
    • (2005) Neuro. Oncol. , vol.7 , Issue.1 , pp. 84-89
    • Weber, E.L.1    Goebel, E.A.2
  • 23
    • 33847626047 scopus 로고    scopus 로고
    • Fatal outcome related to carmustine implants in glioblastoma multiforme
    • Gallego JM, Barcia JA, Barcia-Marino C. Fatal outcome related to carmustine implants in glioblastoma multiforme. Acta Neurochir (Wien). 2007;149(3):261-5.
    • (2007) Acta Neurochir (Wien) , vol.149 , Issue.3 , pp. 261-265
    • Gallego, J.M.1    Barcia, J.A.2    Barcia-Marino, C.3
  • 24
    • 0028400602 scopus 로고
    • In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy
    • Wu MP, et al. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res. 1994;28(3):387-95.
    • (1994) J. Biomed. Mater. Res. , vol.28 , Issue.3 , pp. 387-395
    • Wu, M.P.1
  • 25
    • 38949131870 scopus 로고    scopus 로고
    • Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
    • Darakchiev BJ, et al., Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg. 2008;108(2):236-42.
    • (2008) J. Neurosurg. , vol.108 , Issue.2 , pp. 236-242
    • Darakchiev, B.J.1
  • 26
    • 20944446096 scopus 로고    scopus 로고
    • A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme
    • Limentani SA, et al. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neurooncol. 2005;72(3):241-4.
    • (2005) J. Neurooncol , vol.72 , Issue.3 , pp. 241-244
    • Limentani, S.A.1
  • 27
    • 33846943352 scopus 로고    scopus 로고
    • Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylgua-nine in adults with recurrent malignant glioma: New approaches to brain tumor therapy CNS consortium trial
    • Weingart J, et al. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylgua-nine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol. 2007;25(4):399-404.
    • (2007) J. Clin. Oncol. , vol.25 , Issue.4 , pp. 399-404
    • Weingart, J.1
  • 28
    • 33947191055 scopus 로고    scopus 로고
    • Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
    • Vredenburgh JJ, et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007;13(4):1253-9.
    • (2007) Clin. Cancer Res. , vol.13 , Issue.4 , pp. 1253-1259
    • Vredenburgh, J.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.